圣达生物: 浙江圣达生物药业股份有限公司2025年第二次临时股东大会会议材料

Core Points - The company, Zhejiang Shengda Biological Pharmaceutical Co., Ltd., is holding its second extraordinary general meeting of shareholders on July 23, 2025, to discuss important matters including amendments to the Articles of Association [1][2][4]. Meeting Details - The meeting will take place at the company's conference room located at 18 Shifeng East Road, Fuxi Street, Tiantai County, Zhejiang Province, starting at 13:30 [1]. - Shareholders can participate through both on-site attendance and online voting via the Shanghai Stock Exchange's voting system during specified time slots on the same day [2][4]. Agenda Items - The primary agenda item is to amend the Articles of Association and handle the necessary business registration changes [1][5]. - The company has completed the issuance of 17,840,666 shares, increasing the total number of shares from 171,188,958 to 189,029,624, which raises the registered capital from 171,188,958 RMB to 189,029,624 RMB [4][5]. Changes to Company Structure - The name of one of the company's founders, Zhejiang Hongbo Enterprise Management Co., Ltd., will be changed to Ningbo Xuande Investment Co., Ltd. [5]. - Specific clauses in the Articles of Association will be revised to reflect the changes in total shares and registered capital, while other contents will remain unchanged [5][6]. Legal and Procedural Aspects - The meeting will be conducted in accordance with the company's Articles of Association and relevant laws, ensuring the protection of shareholders' rights and orderly proceedings [2][4]. - A legal representative from Zhejiang Tiance Law Firm will be present to witness the meeting and provide a legal opinion [4].